Lung Cancer Treatment History Events

1929 Fritz Lickint Finds Evidence that Links Lung Cancer and Cigarettes
It is interesting to note, however, that in 1929 (presumably too late to be included in the handbook) the German physician, Fritz Lickint published a paper in which he showed that lung ca...
1983 Nov 10 FDA Approves Bristol Myers Squibb's VePesid
Treating patients with lung cancer and recurrent testicular tumors. It is used in combination with other cancer medications. VePesid is an antineoplastic. It works by stopping the tumo...
1987 Lung Cancer Becomes Leading Cause of Cancer Death in Women
Lung cancer has been the leading cause of cancer death among women since 1987, claiming the lives of 70,490 women in 2009.
1992 Dec 29 FDA Approves Bristol Myers Squibb's Taxol
Taxol is one of the newer chemotherapy drugs, and has been around, and in use for some years. It is an extract from the bark and needles of the yew tree, Taxus brevifolia. Taxol is a whit...
1994 Dec 23 FDA Approves Pierre Fabre's Navelbine
NAVELBINE is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced non-small cell lung cancer (NSCLC...
1995 Feb 27 FDA Approves Teva's Toposar
Treating lung cancer and testicular tumors in patients who have not responded to other treatment. It is used in combination with other cancer medications. Toposar is an antineoplastic....
1996 May 14 FDA Approves Sanofi Aventis's Taxotere
Drug Type: Taxotere is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Taxotere is classified as a "plant alkaloid," a "taxane" and an "antimicrotubule agent." (F...
1996 May 15 FDA Approves Lilly's Gemzar
Gemzar is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell l...
1996 May 17 FDA Approves Bristol Myers Squibb's Etopophos
Treating lung cancer and testicular tumors in patients who have not responded to other treatment. It is used in combination with other cancer medications. Etopophos is an antineoplasti...
2001 Mar 21 FDA Approves BARR's Trexall
Treating certain types of cancer, severe psoriasis, or rheumatoid arthritis in certain patients. It may be used alone or with other medicines. It may also be used for other conditions as ...
2003 May 5 FDA Approves AstraZeneca's Iressa
IRESSA is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxe...
2004 Feb 4 FDA Approves Lilly's Alimta
Alimta® is the very first chemotherapy drug to be approved by the Food and Drug Administration (FDA) to treat patients suffering from malignant pleural mesothelioma cancer. Also known as ...
2004 Feb 26 FDA Approves Genentech's Avastin
Avastin is a cancer medicine that interferes with the growth of cancer cells by blocking the formation and growth of new blood vessels in the tumor which slows their growth. Avastin is...
2004 Nov 18 FDA Approves OSI Pharms' Tarceva
Non-Small Cell Lung Cancer (NSCLC) TARCEVA monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer whose disea...
2007 Oct FDA Approves GlaxoSmithKline's Hycamtin Capsules for Patients with Lung Cancer
Hycamtin (topotecan) is a semi-synthetic derivative of camptothecin and is an anti-tumor drug with topoisomerase I-inhibitory activity. Topoisomerase I relieves torsional strain in DNA by...
2010 Jun 13 Blood Pressure Drugs Linked to Increased Risk of Cancer
A blood pressure drug used by millions of adults could be increasing their risk of cancer, a study has revealed. The use of ARB drugs to treat hypertension is associated with a 'modestly...